Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes

Apolipoprotein E
DOI: 10.1016/j.cell.2024.10.027 Publication Date: 2024-11-11T15:36:28Z
ABSTRACT
While apolipoprotein E (APOE) is the strongest genetic modifier for late-onset Alzheimer's disease (LOAD), molecular mechanisms underlying isoform-dependent risk and relevance of ApoE-associated lipids remain elusive. Here, we report that impaired low-density lipoprotein (LDL) receptor (LDLR) binding lipidated ApoE2 (lipApoE2) avoids LDLR recycling defects observed with lipApoE3/E4 decreases uptake cholesteryl esters (CEs), which are linked to neurodegeneration. In human neurons, addition ApoE carrying polyunsaturated fatty acids (PUFAs)-CE revealed an allelic series (ApoE4 > ApoE3 ApoE2) associated lipofuscinosis, age-related lysosomal pathology resulting from lipid peroxidation. Lipofuscin increased accumulation tau fibrils was elevated in APOE4 mouse brain exacerbation by pathology. Intrahippocampal injection PUFA-CE-lipApoE4 sufficient induce lipofuscinosis wild-type mice. Finally, protective Christchurch mutation also reduced phenocopied ApoE2. Collectively, our data strongly suggest decreased lipApoE-LDLR interactions minimize LOAD reducing deleterious effects endolysosomal targeting pathogenic lipids.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (103)
CITATIONS (10)